This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Friedrich A. Bahmer Dr; Hansotto Zaun Prof
Universitäts-Hautklinik D-6650 Homburg (Saar), West Germany

Arch Dermatol. 1985;121(3):308.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The pyogenic granulomalike lesions reported to occur in rare instances during isotretinoin therapy for severe acne^1,2 prompted us to try the substance in patients with progressive systemic sclerosis (PSS).

Within the last few months, we have treated three female patients suffering from long-standing advanced PSS. They received 20 to 50 mg of oral isotretinoin (13-cis-retinoic acid) daily. After a few weeks, all three experienced considerable subjective improvement. Furthermore, the movement in the finger joints had improved, and, in one patient, the "rat-bite" necrotic lesions of the finger tips had healed.

Vascular changes seem to play an important role in the pathogenesis of PSS.³ An investigation published only very recently showed a lowered angiogenic capability of peripheral blood lymphocytes in PSS.⁴ This finding and the probable angiogenic capability of isotretinoin lends some support to our original idea that the substance might benefit patients . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?